Potential COVID-19 vaccine from China shows promise in animal trials – The Hill

Ross J Burland FXStreet

Chinese researchers who are developing a coronavirus vaccine say it showed promise in animal trials, according to a study published Saturday in the medical journal Cell as The Hill reports.

The article states that the "potential vaccine, called BBIBP-CorV, reportedly produced antibodies that fought against the virus in monkeys, rats, guinea pigs and rabbits."

Key notes

'These results support the further evaluation of BBIBP-CorV in a clinical trial,' researchers said in the paper.

The vaccine is being developed by the Beijing Institute of Biological Products, which is a unit of the China National Pharmaceutical Group (Sinopharm). It is one of five vaccine candidates that is being tested in the country.

Additionally, the article goes on to explain that there are more than 100 potential vaccines in works worldwide, about five of which are in different stages of development around the US.

Moderna, the American biotech company working on a vaccine with the National Institute of Allergy and Infectious Diseases (NIAID), announced Wednesday that it will begin the final testing stages in July.

In its previous phase, Moderna's vaccine showed promising results when tested on animals, much like BBIBP-CorV.

John Mascola, the director of the vaccine research center at NIAID, told The Wall Street Journal that the trials will involve about 30,000 people at more than 50 sites, which will mostly be within the US .

Market implications

Investors seeking bullish markets need some good news following a sobering 24-hours in the markets. More on this here: Biggest decline in the S&P 500 since mid-March, losers fit well with second virus wave fears

Author

Ross J Burland

FXStreet

Ross J Burland, born in England, UK, is a sportsman at heart. He played Rugby and Judo for his county, Kent and the South East of England Rugby team.

GBP/USD remains offered; bears target 1.3600

GBP/USD now leaves behind part of its recent recovery and revisits the low 1.3600s at the beginning of the week. Indeed, Cable trades with a mild downward bias amid decent gains in the Greenback as investors remain wary of upcoming US data releases and the Jackson Hole event.

EUR/USD remains sidelined above 1.1650

EUR/USD trades on the defensive following the closing bell on Wall Street on Monday, hovering around the 1.1660 region and adding to Friday’s small decline. The pair’s pullback comes in response to an acceptable rebound in the US Dollar in a context of generalised caution ahead of key US data releases and Chair Warsh’s speech in Jackson Hole.

Gold poised to extend its bullish run

Gold surrenders part of its initial advance, although it keeps its bullish pace well and sound above the $4,600 mark per troy ounce on Monday. The precious metal’s move higher comes despite slight gains in the US Dollar and a modest pullback in US Treasury yields across the curve.

XRP surged 72%, but is the rally really about XRP?

Ripple (XRP) surged more than 72% in less than a week, its strongest rally since July 2025, as cryptocurrency prices broadly broke out. But the move has a problem: it may have little to do with XRP itself. The token's near-term rally appears to have been driven largely by a broader liquidity shift after the US Treasury expanded long-end bond buybacks, pulling yields lower and lifting risk assets.

Convulsion in credit markets

The United States government just posted a $432.3 billion deficit for July, the largest monthly shortfall since March of 2021. That single burst of red ink pushed the yeartodate deficit to $1.8 trillion, with two months still remaining in fiscal 2026. At this pace, Washington will soon wax nostalgic for the “good old days” when annual deficits were only $2 trillion.

$20 billion offered, $2 billion taken: Why Treasury doubled its buyback cap

The US Treasury moved off its own calendar on Wednesday, and that is the part worth sitting with. At 12:32 GMT, the department said it would at least double the size of liquidity support buyback operations in the 10-year to 20-year and 20-year to 30-year sectors, lifting the maximum from $2 billion per operation to at least $4 billion, effective September 9 and running to November 4.